Correlation Between Oric Pharmaceuticals and Merck
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Merck Company, you can compare the effects of market volatilities on Oric Pharmaceuticals and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Merck.
Diversification Opportunities for Oric Pharmaceuticals and Merck
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Oric and Merck is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Merck go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Merck
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 3.28 times more return on investment than Merck. However, Oric Pharmaceuticals is 3.28 times more volatile than Merck Company. It trades about -0.01 of its potential returns per unit of risk. Merck Company is currently generating about -0.06 per unit of risk. If you would invest 1,125 in Oric Pharmaceuticals on December 11, 2024 and sell it today you would lose (356.00) from holding Oric Pharmaceuticals or give up 31.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oric Pharmaceuticals vs. Merck Company
Performance |
| Timeline |
| Oric Pharmaceuticals |
| Merck Company |
Oric Pharmaceuticals and Merck Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oric Pharmaceuticals and Merck
The main advantage of trading using opposite Oric Pharmaceuticals and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |